5/13/2013

Marina Biotech Announces that Licensee Mirna Therapeutics Reported Initiation of a Phase 1 Clinical Trial of Anticancer Drug MRX34

8/14/2013

Marina Biotech Monetizes UNA Intellectual Property Estate through Agreement with Arcturus Therapeutics

Scroll Up